UY27550A1 - Composición para catéter y usos de la misma - Google Patents

Composición para catéter y usos de la misma

Info

Publication number
UY27550A1
UY27550A1 UY27550A UY27550A UY27550A1 UY 27550 A1 UY27550 A1 UY 27550A1 UY 27550 A UY27550 A UY 27550A UY 27550 A UY27550 A UY 27550A UY 27550 A1 UY27550 A1 UY 27550A1
Authority
UY
Uruguay
Prior art keywords
composition
catheter
same
effective amount
fibrin
Prior art date
Application number
UY27550A
Other languages
English (en)
Spanish (es)
Inventor
Charles P Sembra
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of UY27550A1 publication Critical patent/UY27550A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
UY27550A 2001-11-26 2002-11-26 Composición para catéter y usos de la misma UY27550A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26

Publications (1)

Publication Number Publication Date
UY27550A1 true UY27550A1 (es) 2003-06-30

Family

ID=23302492

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27550A UY27550A1 (es) 2001-11-26 2002-11-26 Composición para catéter y usos de la misma

Country Status (28)

Country Link
US (3) US20030206906A1 (OSRAM)
EP (1) EP1455858A4 (OSRAM)
JP (1) JP4458240B2 (OSRAM)
KR (2) KR20040054803A (OSRAM)
CN (1) CN100478027C (OSRAM)
AR (1) AR037437A1 (OSRAM)
AU (2) AU2002365408B2 (OSRAM)
BR (1) BR0215098A (OSRAM)
CA (1) CA2467645C (OSRAM)
CO (1) CO5580795A2 (OSRAM)
EA (1) EA007594B1 (OSRAM)
EC (2) ECSP045123A (OSRAM)
HR (1) HRP20040502A2 (OSRAM)
HU (1) HUP0600436A3 (OSRAM)
IL (2) IL162083A0 (OSRAM)
IS (1) IS7275A (OSRAM)
ME (1) ME00015B (OSRAM)
MX (1) MXPA04004948A (OSRAM)
MY (1) MY140404A (OSRAM)
NO (1) NO331700B1 (OSRAM)
NZ (1) NZ533029A (OSRAM)
PL (1) PL371760A1 (OSRAM)
RS (1) RS46204A (OSRAM)
TW (1) TWI262794B (OSRAM)
UA (1) UA81235C2 (OSRAM)
UY (1) UY27550A1 (OSRAM)
WO (1) WO2003045466A2 (OSRAM)
ZA (1) ZA200404024B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467645C (en) 2001-11-26 2017-01-17 Genentech, Inc. Composition for removing fibrin-bound blood clots from a catheter
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
MX2009002226A (es) * 2006-08-28 2009-09-07 Omnio Healer Ab Candidatos contra infeccion.
EP2056865B1 (en) 2006-08-28 2013-12-25 Omnio Healer AB Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
WO2008070353A2 (en) * 2006-11-07 2008-06-12 Genentech, Inc. Tissue plasminogen activator variant uses
RU2323001C1 (ru) * 2007-05-30 2008-04-27 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая фибринолитическим действием
EP2160152B1 (en) 2007-06-01 2016-07-27 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
CN103181893A (zh) * 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
EP3307374A4 (en) 2015-06-11 2019-04-10 Proviflo, LLC GRAFT-PORT HEMODIALYSIS SYSTEMS, DEVICES AND METHODS

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484L (fi) * 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
US5000185A (en) * 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
WO1991017724A1 (en) * 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) * 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
ATE246000T1 (de) * 1992-06-03 2003-08-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5362754A (en) * 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
ATE198748T1 (de) 1993-11-24 2001-02-15 Du Pont Pharm Co Isoxazoline und isoxazole derivate als fibrinogen rezeptor antagonisten
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) * 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
WO1998028326A1 (en) 1996-12-23 1998-07-02 Biochem Pharma Inc. Bicyclic thrombin inhibitors
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
EP1161279A1 (en) 1999-03-11 2001-12-12 Du Pont Pharmaceuticals Company Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
WO2000053168A2 (en) * 1999-03-11 2000-09-14 Du Pont Pharmaceuticals Company Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) * 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) * 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
DK1284780T3 (da) 2000-05-10 2008-09-08 Ash Access Technology Inc Kateter-blokeringsoplösning, der indeholder en foto-oxidant
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) * 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
CA2467645C (en) * 2001-11-26 2017-01-17 Genentech, Inc. Composition for removing fibrin-bound blood clots from a catheter
US20070014779A1 (en) * 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
EP1442753B1 (en) 2003-02-03 2007-02-21 Polaschegg, Hans-Dietrich, Dr.techn. Composition for the prevention of indwelling device related infection
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
WO2008070353A2 (en) 2006-11-07 2008-06-12 Genentech, Inc. Tissue plasminogen activator variant uses

Also Published As

Publication number Publication date
HRP20040502A2 (en) 2004-12-31
US20060246050A1 (en) 2006-11-02
AU2002365408B2 (en) 2008-04-24
JP2005510302A (ja) 2005-04-21
NO20042693L (no) 2004-08-25
KR20040054803A (ko) 2004-06-25
CO5580795A2 (es) 2005-11-30
TWI262794B (en) 2006-10-01
WO2003045466A2 (en) 2003-06-05
MXPA04004948A (es) 2004-08-11
US20030206906A1 (en) 2003-11-06
CA2467645A1 (en) 2003-06-05
MY140404A (en) 2009-12-31
EP1455858A2 (en) 2004-09-15
US7829082B2 (en) 2010-11-09
HUP0600436A3 (en) 2010-12-28
ECSP045123A (es) 2004-07-23
CA2467645C (en) 2017-01-17
ECSDI045123S (OSRAM) 2004-07-23
CN100478027C (zh) 2009-04-15
IL162083A0 (en) 2005-11-20
RS46204A (sr) 2006-10-27
AR037437A1 (es) 2004-11-10
US20060257390A1 (en) 2006-11-16
AU2008203131A1 (en) 2008-08-07
TW200303743A (en) 2003-09-16
ZA200404024B (en) 2005-07-27
PL371760A1 (en) 2005-06-27
BR0215098A (pt) 2004-12-14
CN1617738A (zh) 2005-05-18
EA200400712A1 (ru) 2005-06-30
NO331700B1 (no) 2012-02-27
UA81235C2 (en) 2007-12-25
HUP0600436A2 (en) 2006-09-28
KR20100102745A (ko) 2010-09-24
WO2003045466A3 (en) 2003-10-09
JP4458240B2 (ja) 2010-04-28
IS7275A (is) 2004-05-21
NZ533029A (en) 2006-05-26
EP1455858A4 (en) 2006-02-15
MEP8008A (xx) 2010-02-10
IL162083A (en) 2012-12-31
AU2002365408A1 (en) 2003-06-10
ME00015B (me) 2010-06-10
EA007594B1 (ru) 2006-12-29

Similar Documents

Publication Publication Date Title
UY27550A1 (es) Composición para catéter y usos de la misma
AR013024A1 (es) Articulo absorbente descartable que tiene una composicion para el cuidado de la piel que contiene a un inhibidor de enzima y metodo para reducir laactividad enzimatica.
NO20020299D0 (no) Behandling og sammensetning for oppnåelse av antialdring av hud med Corneum Protease aktivering
PA8475001A1 (es) Composiciones estabilizadas
ES2172303T3 (es) Agentes terapeuticos obtenidos por catalisis enzimatica.
AR019735A1 (es) Articulo absorbente adaptado para recibir heces
GB2396820B (en) Absorbent article with fluid treatment agent
MX9701514A (es) Limpieza, desinfeccion y preparacion de lentes de contacto.
DK261490D0 (da) New pharmaceutical compound
BR0008254A (pt) Combinações para o tratamento de doenças que envolvam angiogênese
AR034200A1 (es) Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza
AR031401A1 (es) Adhesivo propicio para la piel y vendaje para heridas revestido con el mismo
ES2079350T3 (es) Procedimiento para la determinacion de la actividad de serina-proteasas o de inhibidores de serina-proteasas.
AR023271A1 (es) Conjugado polimerico capaz de inhibir una o mas enzimas proteoliticas
AR020205A1 (es) Formulacion efervescente esterilizante.
AR020695A1 (es) Metodos para controlar macroinvertebrados en sistemas acuosos
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
GB0412898D0 (en) Absorbent article with fluid treatment agent
AR030647A1 (es) Composicion farmaceutica con actividad de agua especifica
ES2109407T3 (es) Agente de absorcion para agua y soluciones acuosas.
PT1305314E (pt) Agente terapeutico cristalino
PT1380208E (pt) Agente desinfectante com actividade antiparasitica
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
ITTO940409A0 (it) Procedimento di trattamento delle acque usate in una stazione di depu-razione per eliminare le emanazioni odorose nocive.
ITPI20000015V0 (it) Strumento medicale irrigatore di sostanze liquide.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160617